1738 related articles for article (PubMed ID: 28117672)
1. Reprogramming Methods Do Not Affect Gene Expression Profile of Human Induced Pluripotent Stem Cells.
Trevisan M; Desole G; Costanzi G; Lavezzo E; Palù G; Barzon L
Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28117672
[TBL] [Abstract][Full Text] [Related]
2. Sendai Virus-Based Reprogramming of Mesenchymal Stromal/Stem Cells from Umbilical Cord Wharton's Jelly into Induced Pluripotent Stem Cells.
Miere C; Devito L; Ilic D
Methods Mol Biol; 2016; 1357():33-44. PubMed ID: 26246353
[TBL] [Abstract][Full Text] [Related]
3. Generation of human iPSCs from cells of fibroblastic and epithelial origin by means of the oriP/EBNA-1 episomal reprogramming system.
Drozd AM; Walczak MP; Piaskowski S; Stoczynska-Fidelus E; Rieske P; Grzela DP
Stem Cell Res Ther; 2015 Jun; 6(1):122. PubMed ID: 26088261
[TBL] [Abstract][Full Text] [Related]
4. Generation of Patient-Specific induced Pluripotent Stem Cell from Peripheral Blood Mononuclear Cells by Sendai Reprogramming Vectors.
Quintana-Bustamante O; Segovia JC
Methods Mol Biol; 2016; 1353():1-11. PubMed ID: 25523810
[TBL] [Abstract][Full Text] [Related]
5. Establishment of integration-free induced pluripotent stem cells from human recessive dystrophic epidermolysis bullosa keratinocytes.
Matsumura W; Fujita Y; Nakayama C; Shinkuma S; Suzuki S; Nomura T; Abe R; Shimizu H
J Dermatol Sci; 2018 Mar; 89(3):263-271. PubMed ID: 29229433
[TBL] [Abstract][Full Text] [Related]
6. A Comparative View on Easy to Deploy non-Integrating Methods for Patient-Specific iPSC Production.
Manzini S; Viiri LE; Marttila S; Aalto-Setälä K
Stem Cell Rev Rep; 2015 Dec; 11(6):900-8. PubMed ID: 26341105
[TBL] [Abstract][Full Text] [Related]
7. High-efficiency generation of induced pluripotent mesenchymal stem cells from human dermal fibroblasts using recombinant proteins.
Chen F; Zhang G; Yu L; Feng Y; Li X; Zhang Z; Wang Y; Sun D; Pradhan S
Stem Cell Res Ther; 2016 Jul; 7(1):99. PubMed ID: 27473118
[TBL] [Abstract][Full Text] [Related]
8. Induction of pluripotency in long-term cryopreserved human neonatal fibroblasts in feeder-free condition.
Csobonyeiova M; Krajciova L; Nicodemou A; Polak S; Danisovic L
Cell Tissue Bank; 2017 Mar; 18(1):45-52. PubMed ID: 27873029
[TBL] [Abstract][Full Text] [Related]
9. Applying hydrodynamic pressure to efficiently generate induced pluripotent stem cells via reprogramming of centenarian skin fibroblasts.
Vosough M; Ravaioli F; Zabulica M; Capri M; Garagnani P; Franceschi C; Piccand J; Kraus MR; Kannisto K; Gramignoli R; Strom SC
PLoS One; 2019; 14(4):e0215490. PubMed ID: 31022207
[TBL] [Abstract][Full Text] [Related]
10. Generation of induced pluripotent stem cells from muscular dystrophy patients: efficient integration-free reprogramming of urine derived cells.
Afzal MZ; Strande JL
J Vis Exp; 2015 Jan; (95):52032. PubMed ID: 25650629
[TBL] [Abstract][Full Text] [Related]
11. Robust Differentiation of mRNA-Reprogrammed Human Induced Pluripotent Stem Cells Toward a Retinal Lineage.
Sridhar A; Ohlemacher SK; Langer KB; Meyer JS
Stem Cells Transl Med; 2016 Apr; 5(4):417-26. PubMed ID: 26933039
[TBL] [Abstract][Full Text] [Related]
12. Efficient Reprogramming of Canine Peripheral Blood Mononuclear Cells into Induced Pluripotent Stem Cells.
Kimura K; Tsukamoto M; Tanaka M; Kuwamura M; Ohtaka M; Nishimura K; Nakanishi M; Sugiura K; Hatoya S
Stem Cells Dev; 2021 Jan; 30(2):79-90. PubMed ID: 33256572
[TBL] [Abstract][Full Text] [Related]
13. Manipulation of KLF4 expression generates iPSCs paused at successive stages of reprogramming.
Nishimura K; Kato T; Chen C; Oinam L; Shiomitsu E; Ayakawa D; Ohtaka M; Fukuda A; Nakanishi M; Hisatake K
Stem Cell Reports; 2014 Nov; 3(5):915-29. PubMed ID: 25418733
[TBL] [Abstract][Full Text] [Related]
14. New type of Sendai virus vector provides transgene-free iPS cells derived from chimpanzee blood.
Fujie Y; Fusaki N; Katayama T; Hamasaki M; Soejima Y; Soga M; Ban H; Hasegawa M; Yamashita S; Kimura S; Suzuki S; Matsuzawa T; Akari H; Era T
PLoS One; 2014; 9(12):e113052. PubMed ID: 25479600
[TBL] [Abstract][Full Text] [Related]
15. Fluorescent tagged episomals for stoichiometric induced pluripotent stem cell reprogramming.
Schmitt CE; Morales BM; Schmitz EMH; Hawkins JS; Lizama CO; Zape JP; Hsiao EC; Zovein AC
Stem Cell Res Ther; 2017 Jun; 8(1):132. PubMed ID: 28583172
[TBL] [Abstract][Full Text] [Related]
16. Inducing goat pluripotent stem cells with four transcription factor mRNAs that activate endogenous promoters.
Chen H; Zuo Q; Wang Y; Song J; Yang H; Zhang Y; Li B
BMC Biotechnol; 2017 Feb; 17(1):11. PubMed ID: 28193206
[TBL] [Abstract][Full Text] [Related]
17. Blood cell-derived induced pluripotent stem cells free of reprogramming factors generated by Sendai viral vectors.
Ye L; Muench MO; Fusaki N; Beyer AI; Wang J; Qi Z; Yu J; Kan YW
Stem Cells Transl Med; 2013 Aug; 2(8):558-66. PubMed ID: 23847002
[TBL] [Abstract][Full Text] [Related]
18. Generation of Footprint-Free Induced Pluripotent Stem Cells from Human Fibroblasts Using Episomal Plasmid Vectors.
Ovchinnikov DA; Sun J; Wolvetang EJ
Methods Mol Biol; 2015; 1330():37-45. PubMed ID: 26621587
[TBL] [Abstract][Full Text] [Related]
19. Transgene-free disease-specific induced pluripotent stem cells from patients with type 1 and type 2 diabetes.
Kudva YC; Ohmine S; Greder LV; Dutton JR; Armstrong A; De Lamo JG; Khan YK; Thatava T; Hasegawa M; Fusaki N; Slack JM; Ikeda Y
Stem Cells Transl Med; 2012 Jun; 1(6):451-61. PubMed ID: 23197849
[TBL] [Abstract][Full Text] [Related]
20. Nuclear reprogramming with a non-integrating human RNA virus.
Driscoll CB; Tonne JM; El Khatib M; Cattaneo R; Ikeda Y; Devaux P
Stem Cell Res Ther; 2015 Mar; 6(1):48. PubMed ID: 25889591
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]